Skip to main content
Clinical Trials/NL-OMON54091
NL-OMON54091
Recruiting
N/A

Flow dysfunction of hemodialysis vascular access: a randomized controlled trial on the effectiveness of surveillance of arteriovenous fistulas and grafts - FLOW

Medisch Universitair Ziekenhuis Maastricht0 sites417 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Medisch Universitair Ziekenhuis Maastricht
Enrollment
417
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Medisch Universitair Ziekenhuis Maastricht

Eligibility Criteria

Inclusion Criteria

  • 1\. Adult patients aged 18 years or older.
  • 2\. End\-stage renal disease with unlikely recovery of kidney function according
  • to the attending nephrologist.
  • 3\. Arteriovenous fistula or arteriovenous graft as hemodialysis vascular access
  • that fulfills both of the following criteria at the time of trial enrollment:
  • a. Vascular access flow volume of at least 500mL/min; and
  • b. Functional vascular access: the vascular access was cannulated with 2
  • needles and achieved the prescribed access circuit flow in at least 6 dialysis
  • sessions over the past 30 days. Patients who have single needle hemodialysis
  • for reasons other than vascular access dysfunction (e.g. for nocturnal

Exclusion Criteria

  • 1\. Arteriovenous fistulas with multiple venous outflow paths upstream of the
  • cannulation sites, that are not suitable for flow volume measurements using
  • ultrasound dilution (e.g. Gracz fistulas and Ellipsys or WavelinQ endovascular
  • 2\. Home hemodialysis.
  • 3\. Thrombosis of the current vascular access in the past year.
  • 4\. Planned access\-related intervention.
  • 5\. Living donor kidney transplantation, switch to peritoneal dialysis, or
  • switch to home hemodialysis planned within 6 months.
  • 6\. Life expectancy of less than 6 months, in the opinion of the attending
  • nephrologist.

Outcomes

Primary Outcomes

Not specified

Similar Trials